|
|
|
|
|
|
|
|
|
|
Saroja Pharma Industries India Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
|
|
ISIN Demat |
INE0PCL01011
|
|
Book Value (Rs) |
36.42
|
|
|
NSE Code |
SAROJA
|
|
Dividend Yield % |
0.00
|
|
Market Cap(Rs Mn) |
189.16
|
|
|
TTM PE(x) |
18.28
|
|
TTM EPS(Rs) |
2.57
|
|
Face Value (Rs) |
10
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
Incorporation Year
|
14-01 2019
|
|
Registered Office
|
305, Kailash Tower, Shiv Shristi Complex,Goregaon Link Road,Mulund (West), Mumbai,
Maharashtra-400080 .
|
|
ISINNO
|
INE0PCL01011
|
|
Phone
|
022-20810011
|
|
E-mail
|
cs@sarojapharma.com |
|
URL
|
www.sarojapharma.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Biju Nair
|
|
Managing Director
|
Biju Nair
|
|
Company Secretary
|
Nikita Kumar
|
|
Listing
|
NSE
|
|
|
|
|